Search results
Legend Biotech (NASDAQ:LEGN) Reaches New 52-Week Low at $45.52
ETF DAILY NEWS· 5 days agoLegend Biotech Co. (NASDAQ:LEGN – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoCAH is a genetic disease that can affect a child's normal growth and development. Neurocrine stock...
Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
GuruFocus.com via Yahoo Finance· 3 days agoThe company's focus on innovative therapies has positioned it as a notable player in the biotech...
Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 7 days agoStockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report issued on Sunday morning. The firm issued a sell rating on the
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Gold Mining Play Aris Breaks Out
Investor's Business Daily· 6 days agoBull market or bear market? Regardless of what stage of the market cycle we're in, some folks never...
Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com
ETF DAILY NEWS· 3 days agoResearch analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a research report issued on Wednesday. The firm set a ...
Why Biogen Stock Leaped Nearly 5% Higher Today
Motley Fool via Yahoo Finance· 4 days agoThe story was quite different on the bottom line. The biotech grew its non-GAAP (generally accepted accounting principles) adjusted net income by 8% to...
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy...
Motley Fool via Yahoo Finance· 6 days agoThe biotech is also evaluating other promising non-opioid pain therapies in phase 1 and 2 clinical...
Wetzel Investment Advisors Inc. Purchases Shares of 500 SPDR S&P Biotech ETF (NYSEARCA:XBI)
ETF DAILY NEWS· 6 days agoWetzel Investment Advisors Inc. purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, according to its most recent 13F filing with ...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 3 days agoPluvicto "paved the way," says David Song, of Tema ETFs. Tema owns the biotech stock, Fusion, and...
